Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Wild

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometryLeslie F McCoy, Peter F Scholl, Anne E Sutcliffe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinomaHeather R Ferguson, Christopher P Wild, Lesley A Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control studyHeather R Ferguson, Christopher P Wild, Lesley A Anderson, et al.
Molecular Oncology|January 23, 2019
Cancer Prevention EuropeChristopher P Wild, Carolina Espina, Linda Bauld, et al.
Scientific Reports|July 21, 2017
Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell linesHector Hernandez-Vargas, Henri Gruffat, Marie Pierre Cros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agentsLisa J Worrillow, Lois B Travis, Alexandra G Smith, et al.
BMC Public Health|November 11, 2018
Impaired growth in rural Gambian infants exposed to aflatoxin: a prospective cohort studySinead Watson, Sophie E Moore, Momodou K Darboe, et al.
International Journal of Epidemiology|April 10, 2015
Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in The GambiaHector Hernandez-Vargas, Jovita Castelino, Matt J Silver, et al.
Environmental Health Perspectives|July 20, 2011
Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infectionStéphanie Villar, Emilie Le Roux-Goglin, Doriane A Gouas, et al.
Journal of the National Cancer Institute|December 18, 2014
Translational cancer research: balancing prevention and treatment to combat cancer globallyChristopher P Wild, John R Bucher, Bas W D de Jong, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometryLeslie F McCoy, Peter F Scholl, Anne E Sutcliffe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinomaHeather R Ferguson, Christopher P Wild, Lesley A Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control studyHeather R Ferguson, Christopher P Wild, Lesley A Anderson, et al.
Molecular Oncology|January 23, 2019
Cancer Prevention EuropeChristopher P Wild, Carolina Espina, Linda Bauld, et al.
Scientific Reports|July 21, 2017
Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell linesHector Hernandez-Vargas, Henri Gruffat, Marie Pierre Cros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agentsLisa J Worrillow, Lois B Travis, Alexandra G Smith, et al.
BMC Public Health|November 11, 2018
Impaired growth in rural Gambian infants exposed to aflatoxin: a prospective cohort studySinead Watson, Sophie E Moore, Momodou K Darboe, et al.
International Journal of Epidemiology|April 10, 2015
Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in The GambiaHector Hernandez-Vargas, Jovita Castelino, Matt J Silver, et al.
Environmental Health Perspectives|July 20, 2011
Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infectionStéphanie Villar, Emilie Le Roux-Goglin, Doriane A Gouas, et al.
Journal of the National Cancer Institute|December 18, 2014
Translational cancer research: balancing prevention and treatment to combat cancer globallyChristopher P Wild, John R Bucher, Bas W D de Jong, et al.
Pageof 11